Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

JAK inhibition in early-onset somatic, nonclonal STAT5B gain-of-function disease

5 Dec 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytokine Signaling Pathways and Interactions
Share to Eosinophilic Disorders and Syndromes
Share to Immunodeficiency and Autoimmune Disorders

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33290916
DOI: 10.1016/j.jaip.2020.11.050

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

JAK inhibition in early-onset somatic, nonclonal STAT5B gain-of-function diseasePMID 33290916Read ↗

Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea.Semantic proximity Read ↗

JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition.Semantic proximity Read ↗

JAK Inhibition in STAT1 Gain-of-Function–Mediated Treatment-Resistant Autoimmune HepatitisSemantic proximity Read ↗

The Goldilocks Principle of JAKs and STATs: Gain-of function mutations, loss-of-function mutations, and their clinical consequencesSemantic proximity Read ↗

The JAK/STAT conundrum with mutational heterogeneity, immune defects, and the emergence of targeted therapies.Semantic proximity Read ↗

Successful Treatment of Interstitial Lung Disease in STAT3 Gain-of-Function Using JAK InhibitorsSemantic proximity Read ↗

JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional ConsequencesSemantic proximity Read ↗

Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyondSemantic proximity Read ↗

Life-Saving, Dose-Adjusted, Targeted Therapy in a Patient with a STAT3 Gain-of-Function MutationSemantic proximity Read ↗

JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome.Semantic proximity Read ↗

Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.Semantic proximity Read ↗

Gain of function in Jak2V617F-positive T-cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.